Neuromuscular Junction Diseases

Diseases of the neuromuscular junction cause skeletal muscle fatigue and include inherited and acquired disorders that affect presynaptic, intrasynaptic or postsynaptic components. Discover the latest research on neuromuscular junction diseases here.

January 16, 2022
Review

Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options.

Clinical Rheumatology
Riccardo BixioOmbretta Viapiana
January 15, 2022

Myasthenia gravis associated with a pelvic follicular lymphoma.

BMJ Case Reports
Charlotte WillisEmily Johns
January 13, 2022
Review
Open Access

Concurrent myasthenia gravis-related cervical thymoma in a patient with diffuse large B-cell lymphoma: a case report.

Journal of Medical Case Reports
Chutima KunacheewaSanya Sukpanichnant
January 13, 2022
Case Report

A Complicated Case of Postpartum Myasthenic Crisis.

Curēus
Ryan QuigleyErin Miller
January 13, 2022

Optimization of application-driven development of in vitro neuromuscular junction models.

Tissue Engineering. Part B, Reviews
Julie B StricklandEmilia A Solomon
January 13, 2022

Hydrocephalus and myasthenia gravis: neurological manifestations in autoimmune polyendocrine syndrome type II.

Acta neurologica Belgica
Germán Morís, Dolores Colunga
January 10, 2022

Treatment of slow-channel congenital myasthenic syndrome in a Thai family with fluoxetine.

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Charungthai DejthevapornRawiphan Witoonpanich
January 11, 2022
Review
Open Access

Cholinesterases in Tripartite Neuromuscular Synapse.

Frontiers in Molecular Neuroscience
Konstantin A PetrovEric Krejci
January 11, 2022
Review
Open Access

Gut Microbiota as Regulators of Th17/Treg Balance in Patients With Myasthenia Gravis.

Frontiers in Immunology
Pan Chen, Xiangqi Tang
January 11, 2022
Case Report
Open Access

Sintilimab-Induced Myocarditis Overlapping Myositis in a Patient With Metastatic Thymoma: A Case Report.

Frontiers in Cardiovascular Medicine
Zi-Xuan YangQing Zhang
January 8, 2022
Case Report
Open Access

Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis: A Neuromuscular Surprise.

Case Reports in Neurological Medicine
Hassam AliShiza Sarfraz
January 8, 2022
Case Report
Open Access

Myasthenia Gravis Masquerading as Status Asthmaticus.

Case Reports in Pediatrics
Neha PirwaniShashikanth Ambati
January 8, 2022

Clinical, Methodological, and Practical Considerations for Algorithmic Testing in Autoimmune Serology.

The Journal of Applied Laboratory Medicine
Lusia Sepiashvili, Stacy M Kenyon
January 7, 2022
Open Access

Erector spinae plane block for post thoracotomy pain in a patient with myasthenia gravis.

Aǧrı : Ağrı (Algoloji) Derneği'nin Yayın organıdır = The journal of the Turkish Society of Algology
Munise Yıldız
January 7, 2022
Review

PACSIN proteins in vivo: Roles in development and physiology.

Acta Physiologica
Vincent Dumont, Sanna Lehtonen
January 6, 2022

Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis.

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Carolyn TallonBarbara S Slusher
January 5, 2022
Case Report

Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: A case report.

Neuromuscular Disorders : NMD
Christoffer EhrstedtAnna Rostedt Punga

Sign up to follow this feed and discover related papers.

Related Feeds

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

© 2022 Meta ULC. All rights reserved
/feed-previews/neuromuscular-junction-diseases/96eef402-05f4-49bd-aa1d-7fce351f28d0